Toho Pharmaceutical Propose New Pharmacy Model In Japan
This article was originally published in PharmAsia News
One of the major four drug wholesalers in Japan, Toho Holdings' subsidiary Toho Pharmaceutical put out a proposal for a new drug store model in Japan
You may also be interested in...
A nasal spray formulated using compounds already approved by regulatory bodies in Europe and the US can “prevent and slow” transmission of COVID-19, according to UK researchers who are now seeking a partner to commercialize the product.
Russia is promising the best of both worlds – a low price with a near-perfect efficacy. While the basic science is plausible, its best-in-class claims are bound to generate skepticism.
The Belgian biotech has divested its drug discovery services unit in Croatia which was making a nice profit but was not a priority as Galapagos concentrates on setting up its commercial operations in Europe.